Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
Serena Vella(Istituto Ortopedico Rizzoli), Massimo Serra(Istituto Ortopedico Rizzoli)
Cited by 27
Related Papers
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
|Clinical Epigenetics|2015|41
Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
|British Journal of Cancer|2013|38